|
SandostatinDrug - Sandostatin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Octreotide Acetate
Strength -
EQ 0.05MG BASE/ML
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
019667
Product Number -
001
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Oct 21, 1988
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Sandostatin
Octreotide Acetate Eq 0.05mg Base/ml Injectable; Injection
Octreotide Acetate Eq 0.1mg Base/ml Injectable; Injection Octreotide Acetate Eq 0.5mg Base/ml Injectable; Injection Octreotide Acetate (preservative Free) Eq 0.05mg Base/ml Injectable; Injection Octreotide Acetate (preservative Free) Eq 0.1mg Base/ml Injectable; Injection Octreotide Acetate (preservative Free) Eq 0.5mg Base/ml Injectable; Injection Sandostatin Eq 0.05mg Base/ml Injectable; Injection Nystatin-triamcinolone Acetonide 100,000 Units/gm;0.1% Ointment; Topical Octreotide Acetate Eq 0.2mg Base/ml Injectable; Injection Octreotide Acetate Eq 1mg Base/ml Injectable; Injection NewDrugInformation |